Summary
1. Accelerated drug metabolism in liver cells was discovered during studies of the cause of barbiturate tolerance and of the way in which polycyclic hydrocarbons protect against the actions of several carcinogenic compounds. — 2. It is elicited by many lipid soluble drugs and is accompanied by increased synthesis of haem and enzyme proteins. It is due to increased activity of the drug metabolizing microsomal enzyme-complexes in the liver which consist of non specific mixed function oxidases and various transferases. — 3. Acceleration of drug metabolism is accompanied by hypertrophy of smooth intracellular membranes and enlargement of the liver. It is dependent on the concentration of the inducer in the endoplasmic reticulum and seems to be influenced by the stability of a complex formed between the drug and cytochrome P-450, as well as by certain, as yet unidentified properties possessed by certain types of inducing agents. — 4. In man it has been observed in patients during and after treatment with a few drugs which have a high inducing capacity and are prescribed in large doses. — 5. Accelerated drug metabolism might be highly advantageous and beneficial in protecting an organism against an overload of endogenous or exogenous toxic compounds, but it can also be harmful if it results in increased production of toxic metabolites. — 6. It can be regarded as a hitherto unknown pharmacological effect on the regulation of the synthesis-rate of enzymes involved in drug metabolism.
Similar content being viewed by others
References
Faust, E.S.: Über die Ursachen der Gewöhnung an Morphin. Arch. exp. Path. Pharmakol.44, 217 (1900).
Pringsheim, J.: Chemische Untersuchungen über das Wesen der Alkoholtoleranz. Biochem. Z.12, 143 (1908).
Eddy, N.B.: The effect of repeated administration of diethyl-barbituric acid and of cyclohexenyl-ethyl-barbituric-acid. J. Pharmacol. exp. Ther.37, 261 (1929).
Weese, H.: Evipan, ein neuartiges Einschlafmittel. I. Pharmakologie des Evipans. Dtsch. med. Wschr.1932 II, 1205.
Hubbard, Th.F., Goldbaum, L.R.: The mechanism of tolerance to thiopental in mice. J. Pharmacol. exp. Ther.97, 488 (1949).
Axelrod, J.: The enzymatic deamination of amphetamine (Benzedrine). J. biol. Chem.214, 753 (1955).
La Du, B.N. Gaudette, L., Trousof, N., Brodie, B.B.: Enzymatic dealkylation of aminopyrin and other alkylamines. J. biol. Chem.214, 741 (1955).
Quinn, G.P., Axelrod, J., Brodie, B.B.: Species and sex differences in metabolism and duration of action of hexobarbital (Evipan). Fed. Proc.13, 396 (1954).
Robillard, E., D'Iorio, A., Pellerin, J.: Influences endocriniennes sur la désintoxication hépatique du pentobarbital. Un. méd. Can.83, 853 (1954).
Pellerin, J., D'Iorio, A., Robillard, E.: Influence des hormones sexuelles et l'hépatectomie partielle sur l'anesthésie au pentobarbital. Rev. Canad. Biol.13, 257 (1954).
Holck, H.G.O., Kanân, M.A., Mills, L.M., Smith, E.L.: Studies upon the sex-differences in rats in tolerance to certain barbiturates and to nicotine. J. Pharmacol. exp. Ther.60, 1 (1937).
Winton, F.R.: The rat-poisoning substance in red squills. J. Pharmacol. exp. Ther.31, 123 (1927).
Poe, C.F., Suchy, J.F., Witt, N.F.: Toxicity of strychnine for male and female rats of different ages. J. Pharmacol. exp. Ther.58, 239 (1936).
Buchel, L.: Influence des hormones sexuelles sur l'activité de l'hexobarbital chez le rat. Durée du séjour de cet hypnotique dans l'organisme du rat. Anesth. et Analg.11, 268 (1954).
Eichholtz, F., Hotovy, R., Collischonn, P., Knauer, H.: Beeinflussung der Entgiftungszeiten von Avertin und Pentothal-Natrium an der nebennierenlosen Ratte durch Nebennieren-Rindenhormon (Pentothal-Natrium). Arch. exp. Path. Pharmakol.207, 576 (1949).
Remmer, H.: Die Wirkung der Nebennierenrinde auf den Abbau von Pharmaka in den Lebermikrosomen. Naturwiss.45, 522 (1958).
Remmer, H.: Die Verstärkung der Abbaugeschwindigkeit von Evipan durch Glykocorticoide. Naunyn-Schmiedebergs Arch. Pharmacol.233, 184 (1958).
Remmer, H., Alsleben, B.: Die Aktivierung der Entgiftung in den Lebermikrosomen während der Gewöhnung. Klin. Wschr.36, 332 (1958).
Brodie, B., Burns, J.J., Mark, L.C., Lief, Ph.A., Bernstein, E., Papper, E.M.: The fate of pentobarbital in man and dog and a method for its estimation in biological material. J. Pharmacol. exp. Ther.109, 26 (1953).
Alsleben, B.: Der Abbau von Pethidin und anderen Arzneimitteln durch mikrosomale Leberenzyme bei normalen und gewöhnten Ratten. Dissertation, Med. Fak. Freie Universität, Berlin, 1963.
Remmer, H.: Hemmung und Steigerung mikrosomaler Oxydationen durch körpereigene und körperfremde Stoffe. Symp. über Redoxfunktionen cytoplasmatischer Strukturen; Dtsch. Gesellsch. f. Physiol. Chemie u. Österr. Biochem. Gesellsch., Wien, Sept. 1962 (S. 75).
Remmer, H.: Der beschleunigte Abbau von Pharmaka unter dem Einfluß von Luminal. Arch. exp. Path. Pharmakol.235, 279 (1959).
Remmer, H.: Die Beschleunigung des Evipanabbaus unter der Wirkung von Barbituraten. Naturwiss.1958, 189.
Remmer, H., Siegert, M., Krause, K.: Die Aktivierung des Arzneimittelabbaus durch Pharmaka. Arch. exp. Path. Pharmakol.241, 549 (1961).
Remmer, H.: Drug tolerance. CIBA Foundation Symp. on Enzymes and Drug Action, p. 276. London: 1962.
Remmer, H.: Drugs as activators of drug enzymes. Proceed. I. Intern. Pharmacol. Meeting, 1962,VI, 235.
Conney, A.H., Davison, C., Gastel, R., Burns, J.J.: Adaptive increases in drug metabolizing enzymes induced by phenobarbital and other drugs. J. Pharmacol. exp. Ther.130, 1 (1960).
Conney, A.H., Miller, E.C., Miller, J.A.: The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res.16, 450 (1956).
Conney, A.H., Brown, R.R., Miller, J.A., Miller, E.C.: The metabolism of methylated amino azo dyes. VI. Intracellular distribution and properties of the demethylated system. Cancer Res.17, 628 (1957).
Miller, E.C., Miller, J.A., Brown, R.R.: On the inhibitory action of certain polycyclic hydrocarbons on azo dye carcinogenesis. Cancer Res.12, 282 (1952).
Richardson, H.L., Stier, A.R., Borsos-Nachtnebel, E.: Liver tumor inhibition and adrenal histologic responses in rats to which 3′-methyl-4-dimethylamino azobenzene and 20-methylcholanthrene were simultaneously administered. Cancer Res.12, 356 (1952).
Estabrook, R.W., Cooper, D.Y., Rosenthal, O.: The light reversible monoxide inhibition of the steroid C21-hydroxylase system of the adrenal cortex. Biochem. Z.338, 741 (1963).
Omura, T., Sato, R., Cooper, D.Y., Rosenthal, O., Estabrook, R.W.: Function of cytochrome P-450 of microsomes. Fed. Proc.24, 1181 (1965).
Gillette, J.R.: Metabolism of drugs and other foreign compounds by enzymatic mechanisms. Progr. Drug Res.6, 11 (1963).
Remmer, H.: The fate of drugs in the organism. Ann. Rev. Pharmacol.5, 405 (1965).
Smith, R.L., Williams, R.T.: Implications of the conjugation of drugs and other exogenous compounds. In: Glucuronic Acid, chap. 7, p. 457 (ed. G.J. Dutton), Academic Press, 1966.
Dutton, G.J.: The biosynthesis of glucuronides. In: Glucuronic Acid, chap. 3, p. 185 (ed. G.J. Dutton), Academic Press, 1966.
Gillette, J.R.: Biochemistry of drug oxidation and reduction by enzymes in hepatic endoplasmic reticulum. In: Advances in Pharmacology, p. 219 (ed. S. Garattini and P.A. Shore), Academic Press, 1966.
Estabrook, R.W., Hildebrandt, A., Remmer, H., Schenkman, J.B., Rosenthal, O., Cooper, D.Y.: The role of cytochrome P-450 in microsomal mixed function oxidation reactions. In: Biochemie des Sauerstoffs, chap. 5 (ed. B. Hess and Hj. Staudinger), p. 142, Springer-Verlag, 1968.
Mannering, G.J.: Microsomal enzyme systems which catalyze drug metabolism. In: Fundamentals of Drug Metabolism and Disposition, (ed. La Duet al.), Williams and Wilkins (in press).
Remmer, H., Schenkman, J., Estabrook, R.W., Sasame, H., Gillette, J., Narasimhulu, S., Cooper, D.Y., Rosenthal, O.: Drug interactions with hepatic microsomal cytochrome. Molec. Pharmacol.2, 187 (1966).
Schenkman, J.B., Remmer, H., Estabrook, R.W.: Spectral studies of drug interaction with hepatic microsomal cytochrome. Molec. Pharmacol.3, 113 (1967).
Kinoshita, T., Horie, S.: Studies on P-450. III. On the absorption spectrum of P-450 in rabbit liver microsomes. J. Biochem. (Tokyo)61, 26 (1967).
Remmer, H., Estabrook, R.W., Schenkman, J., Greim, H.: Reaction of drugs with microsomal liver hydroxylase: its influence on drug action. Arch. Pharmacol. exp. Path.259, 98 (1968).
Gillette, J.R., Conney, A.H., Cosmides, G.J., Estabrook, R.W., Fouts, J.R., Mannering, G.J.: Microsomes and drug oxidations. Symp. on Microsomes and Drug Oxidations, Bethesda, 1968, p. 547. Academic Press Inc.: 1969.
Gigon, P.L., Gram, T.E., Gillette, J.R.: Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate. Molec. Pharmacol.5, 109 (1969).
Remmer, H., Merker, H.J.: Effect of drugs on the formation of smooth endoplasmic reticulum and drug-metabolizing enzymes. Ann. N. Y. Acad. Sci.123, 79 (1965).
Ernster, L., Orrenius, S.: Substrate induced synthesis of the hydroxylating enzyme system of liver microsomes. Fed. Proc.24, 1190 (1965).
Greim, H., Remmer, H.: Die Wirkung von DDT und Phenobarbital auf mikrosomale hydroxylierende Cytochrome. Arch. Pharmakol. exp. Path.255, 1, 16 (1966).
Remmer, H.: Enzyme induction phenomenon: Effects in vertebrate livers. Proc. 2nd IUPAC Internat. Congr. of Pesticide Chemistry, Tel Aviv, Febr. 1971.
Stramentinoli, G., Remmer, H.: Unpublished.
Remmer, H.: Drug induced changes in the liver endoplasmic reticulum: Association with drug metabolizing enzymes. Science142, 1657 (1963).
Fouts, J.R.: Physiological impairment of drug metabolism. Proc. I. Intern. Pharmacol. Meeting, Aug. 1961, Stockholm, Vol.6, p. 257 (1962).
Remmer, H.: Induction of drug metabolizing enzymes in different animal species. Proc. Europ. Soc. Study Drug Toxic., Vol. XI, Venice, 1969. Excerpta Med. Intern. Congr. Ser. No. 198 (p. 14).
Shuster, L., Jick, H.: The turnover of microsomal protein in the livers of phenobarbital-treated mice. J. Biol. Chem.241, 22, 5361 (1966).
Omura, T., Siekevitz, P., Palade, G.E.: Turnover of constituents of the endoplasmic reticulum membranes of rat hepatocytes. J. biol. Chem.242, 10, 2389 (1967).
Greim, H., Remmer, H.: Stabilisation of heme during the elevation of microsomal cytochromes P-450 and b-5 by phenobarbital in starved rats. Scand. J. clin. Lab. Invest.25, 113 (1970).
Arias, I.M., Doyle, D., Schimke, R.T.: Studies on the synthesis and degradation of proteins of the endoplasmic reticulum of rat liver. J. biol. Chem.244, 12, 3303 (1969.)
Greim, H., Schenkman, J.B., Klotzbücher, M., Remmer, H.: The influence of phenobarbital on the turnover of hepatic microsomal cytochrome b-5 and cytochrome P-450 hemes in the rat. Biochim. biophys. Acta201, 20 (1970).
Kuriyama, Y., Omura, T.: Effects of phenobarbital on the synthesis and degradation of the protein components of rat liver microsomal membranes. J. biol. Chem.244, 8, 2017 (1969).
Kato, R., Jondorf, W.R., Loeb, L.A., Ben, T., Gelboin, H.V.: Studies on the mechanism of drug induced microsomal enzyme activities. V. Phenobarbital stimulation of endogenous messenger RNA and polyuridylic acid-directed L-(14C)-phenylalanine incorporation. Molec. Pharmacol.2, 171 (1966).
Marver, H.S.: The role of heme in the synthesis and repression of microsomal protein. In: Microsomes and Drug Oxidations (J. Gillette, A.H., Conney, G.J., Cosmides, R.W. Estabrook, J.R. Fouts, and G.J. Mannering, eds.), New York, Academic Press, 1969, p. 495.
Bock, K.W., Krauss, E., Fröhling, W.: Regulation of δ-aminolevulinic acid synthetase by drugs and steroids in vivo and in isolated perfused rat liver. Europ. J. Biochem.23, 366 (1971).
Schimke, R.T.: J. biol. Chem. (in press).
Gelobin, H.V., Younger, L.R., Nebert, D.W., Miller, J.M.: In vivo and in vitro studies on the mechanism of microsomal enzyme induction. In: Proc. 4th Intern. Congr. Pharmacol., July, 1969, Basel, p. 287.
Bresnick, E.: Ribonucleic acid polymerase activity in liver nuclei from rats pretreated with 3-methylcholanthrene. Molec. Pharmacol.2, 406 (1966).
Kunz, W., Schnieders, B.: RNA metabolism and induction of extramicrosomal enzymes during liver enlargement due to drugs. In: Proc. 4th Intern. Congr. Pharmacol., p. 326. July 1969, Basel.
Lechner, M.C., Pousada, C.R.: A possible role of liver microsomal alkaline ribonuclease in the stimulation of oxidative drug metabolism by phenobarbital, chlordane and DDT. Biochem. Pharmacol. (in press).
Louis-Ferdinand, R.T., Fuller, G.C.: Supression of hepatic ribonuclease during phenobarbital stimulation of drug metabolism. Biochem. biophys. Res. Comm.38, 811 (1970).
Seifert, J., Remmer, H.: Suppression of synthesis of RNA present in microsomal membranes after administration of phenobarbital. Biochem. Pharmacol.20, 553 (1971).
Remmer, H., Merker, H.-J.: Enzyminduktion und Vermehrung von endoplasmatischem Retikulum in der Leberzelle während der Behandlung mit Phenobarbital (Luminal). Klin. Wschr.41, 276 (1963).
Fouts, J.R., Rogers, L.A.: Morphological changes in the liver accompanying stimulation of microsomal drug metabolizing enzyme activity by phenobarbital, chlordane, benzpyrene or methylcholanthrene in rats. J. Pharmacol. exp. Ther.147, 112 (1965).
Orrenius, S., Ericsson, J.L.E., Ernster, L.: Phenobarbital-induced synthesis of the microsomal drug-metabolizing enzyme system and its relationship to the proliferation of endoplasmic membranes. J. Cell Biol.25, 627 (1965).
Ortega, P.: Light and electron microscopy of dichloro-diphenyltrichloroethane (DDT) poisoning in the rat liver. Lab. Invest.15, 657 (1966).
Kunz, W., Schaude, G., Schmid, W., Siess, M.: Lebervergrößerung durch Fremdstoffe. Arch. Pharmakol. exp. Path.254, 470 (1966).
Koransky, W., Schulte-Hermann, R.: Induction of cell proliferation in the liver by drugs. In: Proc. 4th Intern. Congr. Pharmacol. p. 277, July 1969, Basel.
Remmer, H.: Induction of microsomal hydroxylase. Involvement of a second factor besides cytochrome P-450, H.-S. Zeitschrift für physiologische Chemie349, 1621 (1968).
Hildebrandt, A., Remmer, H., Estabrook, R.W.: Cytochrome P-450 of liver microsomes — one pigment or many. Biochem. biophys. Res. Comm.30, 6, 607 (1968).
Selye, H.: Pharmaco-chemical interrelations among catatoxic steroids. Rev. canad. Biol.29, 49 (1970).
Selye, H.: Hormones and resistance. J. Pharm. Sci.60, 1 (1971).
Selye, H.: Hormones and resistance. Springer-Verlag, Berlin, 1971.
Solymoss, B., Werringloer, J., Tóth, S.: The influence of pregnenolone-16α-carbonitrile on hepatic mixed-function oxygenases. Steroids17, 427 (1971).
Werringloer, J.: Stimulation of hepatic microsomal drug metabolism by pregnenolone-16α-carbonitrile and phenobarbital. Fed. Proc. 1972 (in press).
Garg, B.D., Kovács, K., Blascheck, J.A., Selye, H.: Ultrastructural changes induced by pregnenolone nitrile in the rat liver. J. Pharm. Pharmacol.22, 872 (1970).
Garg, B.D., Szabo, S., Khandekar, J.D., Kovács, K.: Effect of hypophysectomy on pregnenolone-16α-carbonitrile-induced ultrastructural changes in rat liver. Naunyn-Schmiedebergs Arch. Pharmakol.269, 7 (1971).
Schenkman, J.B., Frey, I., Remmer, H., Estabrook, R.W.: Sex differences in drug metabolism by rat liver microsomes. Molec. Pharmacol.3, 516 (1967).
Davies, D.S., Gigon, P.L., Gillette, J.R.: Species and sex differences in electron transport systems in liver microsomes and their relationship to ethylmorphine demethylation. Life Sci.8, II, 85 (1969).
Siegert, M., Remmer, H.: Kumulation und Elimination von Phenobarbital. Arch. exp. Path. Pharmakol.243, 479 (1962).
Conney, A.H.: Enzyme induction by drugs in humans. J. Mond. Pharm.12, 3, 186 (1969).
Cucinell, S.A., Conney, A.H., Sansur, M., Burns, J.J.: Drug interactions in man. I. Lowering effect of phenobarbital on plasma levels of bishydroxycoumarin (Dicumarol) and diphenylhydantoin (Dilantin). Clin. Pharmacol. Ther.6, 420 (1965).
Yaffe, S.J., Levy, G., Matsuzawa, T., Baliah, T.: Enhancement of glucuronide-conjugation capacity in a hyperbilirubinaemic infant due to apparent enzyme induction by phenobarbital. New Engl. J. Med.275, 1461 (1966).
Crigler, J.F., Gold, N.I.: Sodium phenobarbital induced decrease in serum bilirubin in an infant with congenital non-haemolytic jaundice and pruritus. J. Clin. Invest.45, 998 (1966).
Schmid, K., Cornu, F., Imhof, P., Keberle, H.: Die biochemische Deutung der Gewöhnung an Schlafmittel. Schweiz. med. Wschr.94, 235 (1964).
Douglas, J.F., Ludwig, B.J., Smith, N.: Studies on the metabolism of meprobamate. Proc. Soc. exp. Biol. Med.112, 436 (1963).
Chen, W., Vrindten, P.A., Dayton, P.G., Burns, J.J.: Accelerated aminopyrine metabolism in human subjects pretreated with phenylbutazone. Life Sci.1, 35 (1962).
Arnold, K., Gerber, N.: The rate of decline of diphenyl-hydantoin in human plasma. Clin. Pharmacol. Ther.11, 121 (1970).
Schoene, B., Fleischmann, R., von Oldershausen, H.-F., Remmer, H.: Unpublished.
Bledsoe, T., Island, D.P., Ney, R.L., Liddle, G.W.: An effect of o,p'-DDD on the extra-adrenal metabolism of cortisol in man. J. clin. Endocr.24, 1303 (1964).
Hartmann, N.: Teleologisches Denken. p. 81–82. Berlin, 1951.
Remmer, H.: The influence of anaesthetics on drug metabolizing enzymes. Rapport de XXI Congrès d'Anesthésie-Reanimation, Marseille, 1971.
Remmer, H., Schmidt-Volkmar, W.: Unpublished.
Krause, W.: Die Steigerung der Aktivität oxydierender Enzyme in den Lebermikrosomen durch Arzneimittel. Inaug.-Diss., Freie Universität Berlin, 1962.
Kato, R., Vasanelli, P.: Induction of increased meprobamate metabolism in rats pretreated with some neurotropic drugs. Biochem. Pharmacol.11, 779 (1962).
Fujimoto, M.M., Plaa, F.L.: Effect of ethionine and carbon tetrachloride on urethan and phenobarbital induced changes in hexobarbital action. J. Pharmacol. exp. Ther.131, 282 (1961).
Remmer, H.: Der beschleunigte Abbau von Pharmaka in den Lebermikrosomen unter dem Einfluß von Luminal. Arch. exp. Path. Pharmackol.235, 279 (1959).
Remmer, H.: Die Beschleunigung von enzymatischen Oxydationen in den Lebermikrosomen unter dem Einfluß von Barbituraten. Arch. exp. Path. Pharmakol.236, 7 (1959).
Kato, R., Chiesara, E., Vasanelli, P.: Increased activity of microsomal strychnine-metabolizing enzyme induced by phenobarbital and other drugs. Biochem. Pharmacol.11, 913 (1962).
Kato, R.: Induced increase of meprobamate metabolism in rats treated with phenobarbital or phenaglycodol. Med. exp. (Basel),3, 95 (1960).
Remmer, H.: Unpublished.
Kato, R.: Un pretrattamento, eseguito 48 ore prima, con svyriate sostanze può diminuire gli effeti farmacologici del nembutal. Atti della Società Lombarda die Scienze Medico-BiologicheXIV, 778 (1959).
Remmer, H., Schüppel, R.: The influence of ethanol on drug metabolism. In: Alcohol and Alcoholism, p. 73 (ed. R.E. Popham), Univ. of Toronto Press, 1969.
Rubin, E., Hutterer, F., Lieber, C.S.: Ethanol increases hepatic smooth endoplasmic reticulum and drug-metabolizing enzymes. Sci.159, 1469 (1968).
Rubin, E., Bacchin, P., Gang, H., Lieber, C.S.: Induction and inhibition of hepatic microsomal and mitochondrial enzymes by ethanol. Lab. Invest.22, 569 (1970).
Ariyoshi, T., Takabatake, E., Remmer, H.: Drug metabolism in ethanol induced fatty liver. Life Sci.9, 361 (1970).
Cucinell, S.A., Odessky, L., Weiss, M., Dayton, P.G.: The effect of chloral hydrate on bishydroxycoumarin metabolism. J. Amer. med. Ass.197, 366 (1967).
Kuntzman, R., Jacobson, M., Levin, W., Conney, A.H.: Stimulatory effect of N-phenylbarbital (phetharbital) on cortisol hydroxylation in man. Biochem. Pharmacol.17, 565 (1968).
Conney, A.H., Jacobson, M., Schneidman, K., Kuntzman, R.: Induction of liver microsomal cortisol 6β-hydroxylase by diphenylhydantoin or phenobarbital: An explanation for the increased excretion of 6-hydroxycortisol in humans treated with these drugs. Life Sci.4, 1091 (1965).
Kato, R., Chiesara, E.: Increase of pentobarbitone metabolism induced in rats pretreated with some centrally acting compounds. Brit. J. Pharmacol.18, 29 (1962).
Phillips, B.M., Miya, T.A., Yim, G.K.W.: Studies on the mechanism of meprobamate tolerance in the rat. J. Pharmacol. exp. Ther.135, 223 (1962).
Hoogland, D.R., Miya, T.S., Bousquet, W.F.: Metabolism and tolerance studies with chlordiazepoxide-2-14C in the rat. Toxicol. Appl. Pharmacol.9, 116 (1966).
Heubel, F.: Interferenz von Diazepam und Pentobarbital an der Ratte und am Menschen. Arch. exp. Path. Pharmacol.264, 246 (1969).
Wattenberg, L.W., Leong, J.L.: Effects of phenothiazines on protective systems against polycyclic hydrocarbons. Cancer Res.25, 365 (1965).
Breyer, U.: Perazine, chlorpromazine and imipramine as inducers of microsomal drug metabolism. Naunyn-Schmiedebergs Arch. Pharmakol. exp. Path.272, 277 (1972).
Stock, K., Westermann, E.: Untersuchungen über den Mechanismus der narkoseverkürzenden Wirkung von Monoaminoxydase-Hemmstoffen. Arch. exp. Path. Pharmakol.243, 44 (1962).
Dingell, J.V., Gillette, J.R.: Unpublished.
Brazda, F.G., Baucum, R.: The effect of nikethamide on the metabolism of pentobarbital by liver microsomes of the rat. J. Pharmacol. exp. Ther.132, 295 (1961).
Burns, J.J., Conney, A.H., Koster, R.: Stimulatory effect of chronic drug administration on drug-metabolizing enzymes in liver microsomes. Ann. N. Y. Acad. Sci.104, 881 (1963)
Burns, J.J., Cucinell, S.A., Koster, R., Conney, A.H.: Application of drug metabolism to drug toxicity studies. Ann. N. Y. Acad. Sci.123, 273 (1965).
Conney, A.H., Michaelson, I.A., Burns, J.J.: Stimulatory effect of chlorcyclizine on barbiturate metabolism. J. Pharmacol. exp. Ther.132, 202 (1961).
Remmer, H., Siegert, M., Merker, H.-J.: Vermehrung arzneimittelabbauender Enzyme durch Tolbutamid. Arch. exp. Path. Pharmakol.249, 71 (1964).
Dixon, R.L., Fouts, J.R.: Inhibition of microsomal drug metabolic pathways by chloramphenicol. Biochem. Pharmacol.11, 715 (1962).
Cullen, S.I., Catalano, P.M.: Griseofulvin-warfarin antagonism. J. Amer. med. Ass.199, 150 (1967).
Novick, W.J., Stohler, C.M., Swagzdis, J.: The influence of steroids on drug metabolism in the mouse. J. Pharmacol. exp. Ther.151, 139 (1966).
Booth, J., Gillette, J.R.: The effect of anabolic steroids on drug metabolism by microsomal enzymes in rat liver. J. Pharmacol. exp. Ther.137, 374 (1962).
Juchau, M.R., Fouts, J.R.: Effects of norethynodrel and progesterone on hepatic microsomal drug metabolizing enzyme systems. Biochem. Pharmacol.15, 891 (1966).
Stripp, B., Hamrick, M., Zampaglione, N.: Effect of spironolactone treatment of rats on the oxidation of drugs by liver microsomes. Fed. Proc.29, 346, 571 (1970).
Solymoss, B., Classen, H.G., Varga, S.: Increased hepatic microsomal activity induced by spironolactone and other steroids. Proc. Soc. exp. Biol. Med.132, 940 (1969).
Blackham, A., Spencer, P.S.J.: The effect of estrogens and progestins on the response of mice to barbiturates. Brit. J. Pharmacol.37, 129 (1969).
Rümke, C.L., Noordhoek, J.: The influence of lynestrenol on the rate of metabolism of phenobarbital, phenytoin and hexobarbital in mice. Europ. J. Pharmacol.6, 163 (1969).
Cook, L., Toner, J.J., Fellows, E.J.: The effect of β-diethyl-aminoethyldiphenylpropylacetate hydrochloride (SKF No. 525-A) on hexobarbital. J. Pharmacol. exp. Ther.111, 131 (1954).
Kaneko, A., Sakamoto, S., Morita, M., Onoe, T.: Morphological and biochemical changes in rat liver in early stages of ethyl chlorophenoxyisobutyrate administration. Tohoku J. exp. Med.99, 81 (1969).
Hartman, H.A., Tousimis, A.J.: Rat hepatocyte peroxisomes: Ultrastructural alterations following cessation of chronic dietary clofibrate administration. Experientia25, 1248 (1969).
Welch, R.M., Haber, S., Gommi, B.W., Atkins, C., Salvador, R.A.: Effect of clofibrate and 1-methyl-4-piperidyl, bis(p-chlorophenoxy)acetate (Sandoz 42-348) on the metabolism of steroids and drugs by rat liver. Fed. Proc., Fed. Amer. Soc. Exp. Biol.29, 683 (1970).
Ruddon, R.W., Cohen, A.M.: Alteration of enzyme activity in rat liver following the acute and chronic administration of nicotine. Toxicol. Appl. Pharmacol.16, 613 (1970).
Wenzel, D.G., Broadie, L.L.: Stimulatory effect of nicotine on the metabolism of meprobamate. Toxicol. Appl. Pharmacol.8, 455 (1966).
Yamamoto, I., Nagai, K., Kimura, H., Iwatsubo, K.: Nicotine and some carcinogens in special reference to the hepatic drug-metabolizing enzymes. Jap. J. Pharmacol.16, 183 (1966).
Beckett, A.H., Triggs, E.J.: Enzyme induction in man caused by smoking. Nature216, 587 (1967).
Kocsis, J.J., Harkaway, S., Santoyo, M.C., Snyder, R.: Dimethyl sulfoxide: Interactions with aromatic hydrocarbons. Science160, 427 (1968).
Kupfer, D., Balazs, T., Buyske, D.A.: Stimulation of o,p′-DDD of cortisol metabolism in the guinea pig. Life Sci.3, 959 (1964).
Hart, L.G., Shultice, R.W., Fouts, J.R.: Stimulatory effects of chlordane on hepatic microsomal drug metabolism in the rat. Toxicol. Appl. Pharmacol.5, 371 (1963).
Hartl, L.G., Fouts, J.R.: Effects of acute and chronic DDT-administration on hepatic microsomal drug metabolism in the rat. Proc. Soc. exp. Biol. Med.114, 388 (1963).
Ghazal, A., Koransky, W., Portig, J., Vohland, H.W., Klempau, I.: Beschleunigung von Entgiftungsfunktionen durch verschiedene Insektizide. Arch. exp. Path. Pharmakol.249, 1 (1964).
Koransky, W., Portig, J., Vohland, H.W., Klempau, I.: Aktivierung von Mikrosomenenzymen durch Hexachlorcyclohexan-Isomere. Arch. exp. Path. Pharmakol.247, 61 (1964).
Kinoshita, F.K., Frawley, J.P., Du Bois, K.: Quantitative measurement of induction of hepatic microsomal enzymes by various dietary levels of DDT and toxaphene in rats. Toxicol. Appl. Pharmacol.9, 505 (1966).
Conney, A.H., Miller, E.C., Miller, J.A.: Substrate-induced synthesis and other properties of benzpyrene hydroxylase in rat liver. J. biol. Chem.228, 753 (1957).
Acros, J.C., Conney, A.H., Buu-Hoi, Ng.Ph.: Induction of microsomal enzyme synthesis by polycyclic aromatic hydrocarbons of different molecular sizes. J. biol. Chem.236, 1291 (1961).
Cramer, J.W., Miller, J.A., Miller, E.C.: The hydroxylation of the carcinogen 2-acetylaminofluorene by rat liver: Stimulation by pretreatment in vivo with 3-methylcholanthrene. J. biol. Chem.235, 250 (1960).
Gelboin, H.V., Blackburn, N.R.: The stimulatory effect of 3-methylcholanthrene on benzpyrene hydroxylase activity in several rat tissues. Inhibition by actinomycin D and puromycin. Cancer Res.24, 356 (1964).
Mannering, G.J.: Significance of stimulation and inhibition of drug metabolism in pharmacologic testing. In: Selected Pharmacol. Testing Methods (ed. A. Burger), p. 51. New York: Dekker 1968.
Hernandez, P.H., Mazel, P., Gillette, J.R.: Studies on the mechanism of action of mammalian hepatic azo reductase. II. The effects of phenobarbital and 3-methylcholanthrene on carbon monoxide sensitive and insensitive azo-reductase activities. Biochem. Pharmacol.16, 1877 (1967).
Remmer, H., Schenkman, J.B.: Unpublished.
Author information
Authors and Affiliations
Additional information
Presented as Feldberg Foundation Lecture 1972 in St. Mary's Hospital Medical School on March 8th, 1972
Rights and permissions
About this article
Cite this article
Remmer, H. Induction of drug metabolizing enzyme system in the liver. Eur J Clin Pharmacol 5, 116–136 (1972). https://doi.org/10.1007/BF00561756
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561756